An efficacy, safety and pharmacokinetic study on the short-term and long-term use of METFORMIN in obese children and adolescents. - Metformin in obese children and adolescents

Sint Antonius Ziekenhuis0 个研究点目标入组 144 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•The inclusion criteria are subject*s age >= 10 and <= 16 years at study entry, from Caucasian descent, with obesity defined as BMI SDS > 2.3 and with insulin resistance defined as HOMA-IR >= 3.4. In addition an obtained informed consent from subjects and/or parents/caregivers.

•The exclusion criteria are presence of T2DM (American Diabetes Association criteria); presence of endocrine disorders with steroid therapy; suspicion of polycystic ovarium syndrome; height < -1.3 SD of target height; psychiatric illness and eating disorders in particular; use of anti-hyperglycaemic drugs; pregnancy (pregnancy test will be performed, if applicable); (history of) alcohol abuse; impaired renal and/or hepatic function (defined as GFR<80ml/min and ALAT >= 150% of normal value for age); use of ritonavir; use of ACE inhibitors; insufficient knowledge of the Dutch language.

发起方